Department of Chemistry, Hacettepe University, 06800, Beytepe, Ankara, Turkey.
Zanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
Sci Rep. 2024 Jun 10;14(1):13299. doi: 10.1038/s41598-024-60396-w.
Radiation therapy and phototherapy are commonly used cancer treatments that offer advantages such as a low risk of adverse effects and the ability to target cancer cells while sparing healthy tissue. A promising strategy for cancer treatment involves using nanoparticles (NPs) in combination with radiation and photothermal therapy to target cancer cells and improve treatment efficacy. The synthesis of gold NPs (AuNPs) for use in biomedical applications has traditionally involved toxic reducing agents. Here we harnessed dopamine (DA)-conjugated alginate (Alg) for the facile and green synthesis of Au NPs (Au@Alg-DA NPs). Alg-DA conjugate reduced Au ions, simultaneously stabilized the resulting AuNPs, and prevented aggregation, resulting in particles with a narrow size distribution and improved stability. Injectable Au@Alg-DA NPs significantly promoted ROS generation in 4T1 breast cancer cells when exposed to X-rays. In addition, their administration raised the temperature under a light excitation of 808 nm, thus helping to destroy cancer cells more effectively. Importantly, no substantial cytotoxicity was detected in our Au@Alg-DA NPs. Taken together, our work provides a promising route to obtain an injectable combined radio enhancer and photothermally active nanosystem for further potential clinic translation.
放射治疗和光疗是常用的癌症治疗方法,具有副作用风险低、能够靶向癌细胞而保护健康组织等优点。一种有前途的癌症治疗策略是将纳米粒子(NPs)与放射和光热疗法结合使用,以靶向癌细胞并提高治疗效果。用于生物医学应用的金纳米粒子(AuNPs)的合成传统上涉及有毒还原剂。在这里,我们利用多巴胺(DA)-接枝海藻酸钠(Alg)来简便、绿色地合成 Au NPs(Au@Alg-DA NPs)。Alg-DA 缀合物还原了 Au 离子,同时稳定了所得的 AuNPs,防止了聚集,从而得到了具有较窄粒径分布和提高稳定性的颗粒。当 4T1 乳腺癌细胞暴露于 X 射线时,可注射的 Au@Alg-DA NPs 显著促进了 ROS 的产生。此外,在 808nm 的光激发下,它们的给药提高了温度,从而有助于更有效地破坏癌细胞。重要的是,我们的 Au@Alg-DA NPs 没有检测到明显的细胞毒性。总之,我们的工作为获得可注射的联合放射增强剂和光热活性纳米系统提供了有前途的途径,以进一步进行潜在的临床转化。
Photodiagnosis Photodyn Ther. 2023-6
Pharmaceuticals (Basel). 2025-7-22
Nat Rev Cancer. 2025-8-1
Nanomaterials (Basel). 2025-2-19
Nanoscale. 2023-8-3
Chem Rev. 2023-6-14
ACS Appl Bio Mater. 2023-5-15
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023
ACS Appl Bio Mater. 2023-2-20